Healthy volunteers help test Easier-to-Take seizure drug
NCT ID NCT07176832
First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 28 times
Summary
This study tested two versions of the seizure drug stiripentol (capsules vs. a liquid suspension) in 24 healthy adults to see if they work the same in the body. The goal is to offer a more convenient option for people with Dravet syndrome, a severe childhood epilepsy. Participants took a single dose of each form and had blood samples taken to measure drug levels. The study also checked safety and how the liquid tasted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
3 Chemin d'Armancourt
Compiègne, 60200, France
-
EUROFINS OPTIMED, 1 rue des Essarts
Gières, 38610, France
Conditions
Explore the condition pages connected to this study.